Literature DB >> 9718581

Peptide and peptidomimetic libraries. Molecular diversity and drug design.

F al-Obeidi1, V J Hruby, T K Sawyer.   

Abstract

Various techniques for generation of peptide and peptidomimetic libraries are summarized in this article. Multipin, tea bag, and split-couple-mix techniques represent the major methods used to make peptides and peptidomimetics libraries. The synthesis of these libraries were made in either discrete or mixture format. Peptides and peptidomimetics combinatorial libraries were screened to discover leads against a variety of targets. These targets, including bacteria, fungus, virus, receptors, and enzymes were used in the screening of the libraries. Discovered leads can be further optimized by combinatorial approaches.

Mesh:

Substances:

Year:  1998        PMID: 9718581     DOI: 10.1007/bf02915794

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  44 in total

1.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

2.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.

Authors:  B Fleckenstein; H Kalbacher; C P Muller; D Stoll; T Halder; G Jung; K H Wiesmüller
Journal:  Eur J Biochem       Date:  1996-08-15

4.  Genomic sciences and the medicine of tomorrow.

Authors:  J Drews
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

5.  Sculpted immunogens; B-cell epitope optimization using constrained secondary structure libraries.

Authors:  J Urban; M Qabar; C Sia; M Klein; M Kahn
Journal:  Bioorg Med Chem       Date:  1996-05       Impact factor: 3.641

6.  Design of peptides, proteins, and peptidomimetics in chi space.

Authors:  V J Hruby; G Li; C Haskell-Luevano; M Shenderovich
Journal:  Biopolymers       Date:  1997       Impact factor: 2.505

7.  Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library.

Authors:  R N Zuckermann; E J Martin; D C Spellmeyer; G B Stauber; K R Shoemaker; J M Kerr; G M Figliozzi; D A Goff; M A Siani; R J Simon
Journal:  J Med Chem       Date:  1994-08-19       Impact factor: 7.446

8.  The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.

Authors:  Z Songyang; B Margolis; M Chaudhuri; S E Shoelson; L C Cantley
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

9.  A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.

Authors:  S Hollenbach; U Sinha; P H Lin; K Needham; L Frey; T Hancock; A Wong; D Wolf
Journal:  Thromb Haemost       Date:  1994-03       Impact factor: 5.249

10.  Inhibitors of human heart chymase based on a peptide library.

Authors:  M Bastos; N J Maeji; R H Abeles
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more
  3 in total

1.  Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues.

Authors:  D Herrera-Ruiz; Q Wang; O S Gudmundsson; T J Cook; R L Smith; T N Faria; G T Knipp
Journal:  AAPS PharmSci       Date:  2001

2.  Fully automated synthesis of (phospho)peptide arrays in microtiter plate wells provides efficient access to protein tyrosine kinase characterization.

Authors:  Carl Saxinger; Thomas P Conrads; David J Goldstein; Timothy D Veenstra
Journal:  BMC Immunol       Date:  2005-01-12       Impact factor: 3.615

3.  Feasibility of β-sheet breaker peptide-H102 treatment for Alzheimer's disease based on β-amyloid hypothesis.

Authors:  Lai-xiang Lin; Xiang-yu Bo; Yuan-zhen Tan; Feng-xian Sun; Ming Song; Juan Zhao; Zhi-hong Ma; Mei Li; Kai-jun Zheng; Shu-Mei Xu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.